Portfolio/Cambium

Cambium

Next-Gen Defense Prime Focused on New Materials — Cambium Biomaterials has pioneered a groundbreaking platform revolutionizing the way materials are developed and manufactured.

Cambium: a rocket ascending through the cloudsCambium
MVP × Cambium

What we build next starts with what we build from.

Why we invested

MVP saw Cambium tackling one of the hardest challenges in advanced materials, turning breakthrough science into a scalable business. The company paired meaningful non-dilutive government funding with a team committed to building and selling products, not stopping at research or licensing. With experienced founders who understood both the science and the work of commercialization, we saw a path to pursue ambitious technical development while building toward meaningful scale.

Partnership

The best support doesn't always start with an ask. As Cambium has moved from technical development toward larger-scale manufacturing and commercialization, MVP has stayed close enough to anticipate where our network can help next. That has meant bringing in specialized talent, manufacturing expertise, strategic partners, and government relationships as new priorities emerge.

What we do for them

  • Source and introduce specialized technical and executive talent
  • Connect Cambium with manufacturing and automation expertise as it scales production
  • Create strategic relationships across aerospace, defense, government, and advanced manufacturing
  • Build commercial and technical partnerships across the MVP portfolio
In their words

What Cambium says about us.

"What stands out about MVP as an investor on our cap table is that they're always there when you need them, but they're equally proactive in finding ways to help—from making great introductions to creating valuable collaboration opportunities—an invaluable combination which you rarely find."
SW
Simon Waddington

Building something like Cambium?